Optimising the tolerogenic potential of a ‘vaccine’ for type 1 diabetes by topical betamethasone therapy

47th Annual Meeting of the European Association for the Study of Diabetes

3.15 pm Thursday 15th September 2011
Session: OP33 : Immunology
Speaker: Dr Mohammad Alhadj Ali
Venue: Lusitano Hall, Feira Internacional de Lisboa, Lisbon, Portugal